Hosting Call at 5:00 pm
ET on Tuesday, May 31st
AGM Scheduled for June
22nd at 11:00 am
ET
CALGARY,
AB, May 24, 2022 /CNW/ - Nanalysis Scientific
Corp. ("the Company", (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1) a
leader in portable NMR machines and MRI technology for healthcare
and industrial applications announces that on Tuesday May 31,
2022 Chief Executive Officer Sean Krakiwsky and Chief Financial Officer
Luke Caplette will host a conference
call at 5:00 P.M. Eastern Time to
discuss the results for the quarter ending March 31, 2022. The Company will file with
SEDAR the day before and put out a release the day of the
call.
Investors interested in participating on the live first quarter
call can dial 1-888-664-6392 or 416-764-8659 from abroad. Investors
can also access the call online through a listen-only webcast here:
https://app.webinar.net/NMnWA6QxEr9, or on the investor
relations section of the Company's website HERE.
The webcast will be archived on the Company's investor relations
webpage for at least 90 days and a telephonic playback will be
available for seven days after the conference call by calling
1-888-390-0541 or 416-764-8677, conference ID #991626.
In light of the public health emergency associated with the
Covid-19 Pandemic, the Company is requesting all shareholders
refrain from attending the Annual General Meeting ("AGM") in person
and, instead, to vote by proxy or by voting instruction form.
Those investors wishing to attend the AGM virtually can dial in
using the following numbers: 1-888-664-6392 or 416-764-8659
from abroad. Additionally, the meeting will be webcast using
the following link: https://app.webinar.net/8A5lnVP0vQB.
About Nanalysis Scientific
Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA:1N1)
Nanalysis trades on the TSX Venture Exchange (TSXV)
in Canada with ticker symbol 'NSCI', OTC and
the Frankfurt exchange under the ticker symbol '1N1'. The
company's business is what we term "MRI and NMR for industry". The
company develops and manufactures portable Nuclear Magnetic
Resonance (NMR) spectrometers or analyzers for laboratory and
industrial markets. The NMReady-60™ was the first full-feature
portable NMR spectrometer in a single compact enclosure requiring
no liquid helium or any other cryogens. The company has followed-up
that initial offering with new products and continues to have a
strong innovation pipeline. Nanalysis recently announced that it
has begun selling a 100MHz device in 2020. The Company's new device
will be the most powerful and most advanced compact NMR device ever
brought to market.
Nanalysis devices are used in many industries (oil and gas,
chemical, mining, pharma, biotech, flavor and fragrances,
agrochemicals, law enforcement, and more) as well as numerous
government and university research labs around the world. The
Company continues to exploit new global market opportunities
independently and with partners.
With the recent acquisition of K'(Prime) Technologies Inc.
(KPrime), the company maintains a North American sales and service
company of over 40 individuals who cover scientific instrumentation
for pharma, food, chemical and oil & gas customers, as well as
imaging systems for security applications.
Additionally, the Company has a 43% ownership in Quad Systems AG
("Quad Systems"), with an option to purchase the remaining shares.
Quad Systems is a Zurich-based Nuclear Magnetic Resonance
(NMR) company focused on high-field NMR for pharmaceutical and
other vertical markets.
Notice regarding Forward Looking
Statements and Legal Disclaimer
This news release contains certain "forward-looking statements"
within the meaning of such statements under applicable securities
law. Forward-looking statements are frequently characterized by
words such as "anticipates", "plan", "continue", "expect",
"project", "intend", "believe", "anticipate", "estimate", "may",
"will", "potential", "proposed", "positioned" and other similar
words, or statements that certain events or conditions "may" or
"will" occur. These statements are only predictions. Various
assumptions were used in drawing the conclusions or making the
projections contained in the forward-looking statements throughout
this news release. Forward-looking statements are based on the
opinions and estimates of management at the date the statements are
made and are subject to a variety of risks and uncertainties and
other factors that could cause actual events or results to differ
materially from those projected in the forward-looking statements.
The Company is under no obligation, and expressly disclaims any
intention or obligation, to update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise, except as expressly required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services
Provider accepts responsibility for the adequacy or accuracy of
this release.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/nanalysis-announces-first-quarter-2022-conference-call-and-virtual-annual-general-meeting-301553551.html
SOURCE Nanalysis Scientific Corp.